Search alternatives:
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
21381
The effects of purmorphamine and Msi1 knockdown on p21<sup>CIP1,WAF1</sup> and c-Myc expression.
Published 2013“…Purmorphamine treatment decreased and increased the expression of p21<sup>CIP1,WAF1</sup> (<b>A</b>) and c-Myc (<b>B</b>), respectively. …”
-
21382
Image 3_Hydrogel and scalp/skin conductivities impact dose from tumor treating fields.png
Published 2025“…Although scalp hotspots increased or decreased by +1.5%, −0.1%, and −0.9% in E<sub>5%</sub>, SAR<sub>5%</sub>, and CD<sub>5%</sub>, the skin hotspots increased by as much as +23.5%, +45.7%, and +20.6%, respectively. …”
-
21383
Image 2_Hydrogel and scalp/skin conductivities impact dose from tumor treating fields.png
Published 2025“…Although scalp hotspots increased or decreased by +1.5%, −0.1%, and −0.9% in E<sub>5%</sub>, SAR<sub>5%</sub>, and CD<sub>5%</sub>, the skin hotspots increased by as much as +23.5%, +45.7%, and +20.6%, respectively. …”
-
21384
Image 1_Hydrogel and scalp/skin conductivities impact dose from tumor treating fields.png
Published 2025“…Although scalp hotspots increased or decreased by +1.5%, −0.1%, and −0.9% in E<sub>5%</sub>, SAR<sub>5%</sub>, and CD<sub>5%</sub>, the skin hotspots increased by as much as +23.5%, +45.7%, and +20.6%, respectively. …”
-
21385
-
21386
-
21387
-
21388
-
21389
-
21390
-
21391
-
21392
-
21393
Astilbin exerts anti-hypersensitivity by regulating metabolic demand and neuronal activity in rodent model of neuropathic pain
Published 2024“…</p> <p>In experiments conducted on neuropathic rats, both systemic and intrathecal administration of astilbin, an essential constituent, exhibited a noteworthy and dose-dependently decrease in chronic and acute pain behaviours. …”
-
21394
-
21395
Tubulin-Destabilizing Agent BPR0L075 Induces Vascular-Disruption in Human Breast Cancer Mammary Fat Pad Xenografts
Published 2012“…The current study evaluated the vascular-disrupting activity of BPR0L075 in human breast cancer mammary fat pad xenografts using dynamic bioluminescence imaging. A single dose of BPR0L075 (50 mg/kg, intraperitoneally (i.p.)) induced rapid, temporary tumor vascular shutdown (at 2, 4, and 6 hours); evidenced by rapid and reproducible decrease of light emission from luciferase-expressing orthotopic MCF7 and MDA-MB-231 breast tumors after administration of luciferin substrate. …”
-
21396
-
21397
-
21398
-
21399
-
21400